Volunteer with AMCP Foundation
Give the gift of time by volunteering. The AMCP Foundation has opportunities for you to donate your time. Volunteering is [...]
The AMCP Podcast Powered by PopHealth Week Launches Next Week
AMCP is proud to partner with renowned health care experts Fred Goldstein and Gregg Masters from PopHealth Week to launch [...]
Panalgo’s IHD Platform to Be Used by the EU Medicines Agency for Real-World Data Analytics
Panalgo, a leading healthcare analytics company, today announced that its Instant Health Data (IHD) platform will be used by the European Medicines Agency (EMA) to [...]
Tracing the Health Care Experience Informs Decision-making
Mapping the patient journey is a worthwhile exercise to undertake because it answers critical questions of interest to all health [...]
Why Population Health Isn’t the ‘Virtuous’ Approach
Mark Ganz isn't a fan of healthcare's fixation on population health. Ganz, who recently left the role of CEO of Cambia [...]
Driving More Value and Cost Savings With SDOH Data
Getting a Social Determinant of Health (SDOH) initiative off the ground requires thoughtful coordination and analysis between analytics teams, clinicians, [...]
ICER Seeks Applications for New Health Technology Assessment Fellowship
The Institute for Clinical and Economic Review (ICER) is now accepting applications for the inaugural cycle of a new Health [...]
RxSense Joins with Hy-Vee to Launch New PBM Vivid Clear Rx
RxSense was founded in 2015 with a singular focus on developing technology solutions that improve healthcare transparency and access to [...]
Healthcare Venture Launched by Amazon, JPMorgan and Berkshire Hathaway Goes Bust
Haven—the healthcare company formed by Amazon, JPMorgan Chase and Berkshire Hathaway—is apparently no more. The healthcare company began telling employees [...]
Hospitals Lose Another Attempt to Stave Off Price Transparency
A federal appeals court ruled against hospitals' efforts to stop regulators from forcing them to reveal the secret negotiated prices [...]
How Does Cost-Sharing Impact Spending Growth and Cost-Effective Treatments?
The growth of health care spending has been a longstanding policy concern. Over the years, several innovations have been proposed [...]
Impact of the Pandemic on Medical and Scientific Affairs
In the latest episode of Impetus Digital's Fireside Chat, Dr. Shurjeel Choudhri, SVP and Head, Medical and Scientific Affairs, Bayer [...]
The Medical Science Liaison-DISC Personality Types Survey
The MSL role is constantly evolving and facing new challenges. MSLs are both scientific experts and relationship managers. As such, [...]
Trends That Matter for COVID Vaccine Distribution
As details continue to emerge about the availability of COVID-19 vaccines and how they will be administered, the role that [...]
Drug Wholesale Prices Impact Payer Spending, Out-of-pocket Costs
Increases in drug wholesale list prices have a trickle-down effect that negatively impacts patient financial responsibility, such as out-of-pocket costs, [...]
Use of Real-world Evidence in Economic Assessments of Pharmaceuticals in the US
In a recent study, investigators from the University of Washington School of Pharmacy reviewed cost-effectiveness and budget impact analyses in [...]
How Healthcare is Leveraging Real-World Data to Improve Outcomes
To improve outcomes during the COVID-19 pandemic and beyond, organizations are using real-world data for efficient and effective decision-making. At [...]
Scientist.com Reflects on the Resounding Successes of 2020
As 2020 comes to a close, we'd like to thank you for supporting our mission here at Scientist.com. Whether you [...]
Employee Health Data Analyses Must Include Race And Ethnicity
As the COVID-19 pandemic has highlighted, at the core of racial equity and social justice movements are health disparities along [...]
[On-demand Conference] Real World Evidence: Meet the Future with Confidence
COVID-19 is impacting all of us and challenging previous ways of working. This is a period of disruption. In this [...]
NICE Updates Methods for Health Technology Evaluations
On November 6, 2020, NICE published a summary of its proposed changes to health technology evaluation methods. NICE periodically assesses its methods [...]
eBook: The role of RWE in FDA approvals
As industry prepares for the FDA’s draft RWE guidance in 2021, Aetion conducted a systematic review of FDA approval documents [...]
ICER Publishes Final Evidence Report for Bladder Cancer Therapies
The Institute for Clinical and Economic Review (ICER) today released a Final Evidence Report and Report-at-a-Glance assessing the comparative clinical effectiveness and value of [...]
PRECISIONxtract Increasing Life Sciences Commercialization Capabilities
PRECISIONxtract, a Precision Value & Health team, announced the launch of two new and innovative product lines, EHR Connect™ and Access [...]
Addressing the Affordability Crisis of Cell & Gene Therapies
In a recent Reuters Events poll, 43% of pharma said that reimbursement policy and legislation (e.g Best Price) is the [...]